Tenofovir disoproxil fumarate withdrawal and cardiovascular risk – Authors' reply

Research output: Contribution to journal › Comment/debate › Research › peer-review

Standard

Tenofovir disoproxil fumarate withdrawal and cardiovascular risk – Authors' reply. / writing group and the RESPOND study group.

In: The Lancet HIV, Vol. 10, No. 1, 2023, p. e9-e10.

Research output: Contribution to journal › Comment/debate › Research › peer-review

Harvard

writing group and the RESPOND study group 2023, 'Tenofovir disoproxil fumarate withdrawal and cardiovascular risk – Authors' reply', The Lancet HIV, vol. 10, no. 1, pp. e9-e10. https://doi.org/10.1016/S2352-3018(22)00367-8

APA

writing group and the RESPOND study group (2023). Tenofovir disoproxil fumarate withdrawal and cardiovascular risk – Authors' reply. The Lancet HIV, 10(1), e9-e10. https://doi.org/10.1016/S2352-3018(22)00367-8

Vancouver

writing group and the RESPOND study group. Tenofovir disoproxil fumarate withdrawal and cardiovascular risk – Authors' reply. The Lancet HIV. 2023;10(1):e9-e10. https://doi.org/10.1016/S2352-3018(22)00367-8

Author

writing group and the RESPOND study group. / Tenofovir disoproxil fumarate withdrawal and cardiovascular risk – Authors' reply. In: The Lancet HIV. 2023 ; Vol. 10, No. 1. pp. e9-e10.

Bibtex

@article{9ca4755d8818477eb8df779330a5ce1f,
title = "Tenofovir disoproxil fumarate withdrawal and cardiovascular risk – Authors' reply",
author = "Bastian Neesgaard and Lauren Greenberg and Lars Peters and Amanda Mocroft and Lene Ryom and {writing group and the RESPOND study group}",
year = "2023",
doi = "10.1016/S2352-3018(22)00367-8",
language = "English",
volume = "10",
pages = "e9--e10",
journal = "The Lancet HIV",
issn = "2352-3018",
publisher = "TheLancet Publishing Group",
number = "1",

}

RIS

TY - JOUR

T1 - Tenofovir disoproxil fumarate withdrawal and cardiovascular risk – Authors' reply

AU - Neesgaard, Bastian

AU - Greenberg, Lauren

AU - Peters, Lars

AU - Mocroft, Amanda

AU - Ryom, Lene

AU - writing group and the RESPOND study group

PY - 2023

Y1 - 2023

U2 - 10.1016/S2352-3018(22)00367-8

DO - 10.1016/S2352-3018(22)00367-8

M3 - Comment/debate

C2 - 36566083

AN - SCOPUS:85144515362

VL - 10

SP - e9-e10

JO - The Lancet HIV

JF - The Lancet HIV

SN - 2352-3018

IS - 1

ER -

ID: 397610462